Effectiveness and safety of dexamphetamine sulfate (Attentin®) in the routine treatment of children and adolescents with ADHD: results from a 12-month non-interventional study
Authors
Henrik Uebel-von Sandersleben
University Medical Center Göttingen, Department of Child and Adolescent Psychiatry and Psychotherapy, Göttingen, Germany
Oliver Dangel
MEDICE Arzneimittel Pütter GmbH & Co KG, Iserlohn, Germany
Roland Fischer
MEDICE Arzneimittel Pütter GmbH & Co KG, Iserlohn, Germany
Michaela Ruhmann
MEDICE Arzneimittel Pütter GmbH & Co KG, Iserlohn, Germany
Michael Huss
Johannes Gutenberg-University, Mainz, Germany
DOI: https://doi.org/10.21307/sjcapp-2021-009 | Journal eISSN: 2245-8875
Language: English
Page range: 73 - 86
Published on: Apr 23, 2021
Published by: Psychiatric Research Unit
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year
Keywords:
Related subjects:
© 2021 Henrik Uebel-von Sandersleben, Oliver Dangel, Roland Fischer, Michaela Ruhmann, Michael Huss, published by Psychiatric Research Unit
This work is licensed under the Creative Commons Attribution 4.0 License.